Tatva Chintan Pharma Chem Limited Capital Reinvestment Ratio
Tatva Chintan Pharma Chem Limited capital reinvestment ratio. Tatva Chintan Pharma Chem Limited (TATVA) has a Capital Reinvestment Ratio of 3.09x as of March 2025, meaning it reinvests 3% of its operating cash flow (Rs246.71 Million) in capital expenditures (Rs762.72 Million). Check Tatva Chintan Pharma Chem Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Tatva Chintan Pharma Chem Limited (2018–2025)
Capital reinvestment ratio of Tatva Chintan Pharma Chem Limited from 2018 to 2025. This chart tracks Tatva Chintan Pharma Chem Limited's Capital Reinvestment Ratio across 8 annual periods. Also explore TATVA net asset momentum to track the company's year-over-year net asset growth rate.
Tatva Chintan Pharma Chem Limited Capital Reinvestment Ratio by Year (2018–2025)
Tatva Chintan Pharma Chem Limited capital reinvestment ratio by year from 2018 to 2025. For the full cash flow conversion analysis, see how efficiently does Tatva Chintan Pharma Chem Limited generate cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.09x | Rs246.71 Million | Rs762.72 Million | ▲ +135.9% |
| 2024 | 1.31x | Rs980.44 Million | Rs1.29 Billion | ▼ -82.1% |
| 2023 | 7.31x | Rs277.83 Million | Rs2.03 Billion | ▲ +67.1% |
| 2022 | 4.38x | Rs203.78 Million | Rs891.57 Million | ▲ +407.4% |
| 2021 | 0.86x | Rs243.19 Million | Rs209.70 Million | ▼ -54.7% |
| 2020 | 1.90x | Rs253.12 Million | Rs481.72 Million | ▲ +43.1% |
| 2019 | 1.33x | Rs73.56 Million | Rs97.86 Million | ▼ -54.5% |
| 2018 | 2.93x | Rs104.12 Million | Rs304.61 Million | — |